News

12/6/2022
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
12/3/2022
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence Portland Medical Center.
12/2/2022
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.
11/23/2022
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence St. Vincent Medical Center.
11/18/2022
A joint statement from Kaiser Permanente, Legacy Health, OHSU Health and Providence
11/23/2022
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
11/7/2022
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
10/17/2022
Learn about some changes that will be taking place at the Center for Medically Fragile Children, with an expansion of adult intermediate care.
9/13/2022
Providence’s team of certified nursing assistants use technology to keep some of our most vulnerable patients safe, 24 hours a day, without ever stepping foot inside their rooms.
10/10/2022
Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.
9/6/2022
New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.
8/15/2022
New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink